05/2024

News Feed Opinion Career Insight Dialogues Blog Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

05/2024

May 23, 2024, 13:22 | Blog
Wei Zhang: Blast from the past
Wei Zhang, Director of Center for Cancer Genomics and Precision Oncology at Wake Forest Baptist…
May 23, 2024, 13:21 | Societies
Join our Scientific Symposium Celebrating Steven A. Rosenberg's 50 Years - NCI Center for Cancer Research
NCI Center for Cancer Research shared on LinkedIn:  “Register Now: Join us at our Scientific…
May 23, 2024, 13:17 | Insight
Julie McCrossin: Helpful insights and practical tips for fellow patients receiving radiation therapy for a brain tumour
Julie McCrossin, Broadcaster, MC, Cancer Survivor and Community Educator, shared on LinkedIn: “Helpful insights and…
May 23, 2024, 13:10 | Societies
Updated ESMO Clinical Practice Guideline on Renal Cell Carcinoma - ESMO
ESMO – European Society for Medical Oncology posted on LinkedIn: “Updated Renal Cell Carcinoma: ESMO…
May 23, 2024, 13:08 | Blog
Miguel Bronchud: Too many different treatments options for some cancer patients? Or not enough?
Miguel Bronchud, Co-Founder of Regenerative Medicine Solutions, shared on LinkedIn: “Too many different treatments options…
May 23, 2024, 13:06 | Drugs
Ajay Major: Outcomes for DLBCL in CR at time of CAR-T infusion from CIBMTR
Ajay Major, Assistant Professor at the University of Colorado School of Medicine, recently shared a…
May 23, 2024, 13:04 | Blog
Tom Powles on the NADINA trial
Tom Powles, Director of Barts Cancer Center, shared a post on X: "The NADINA trial…
May 23, 2024, 13:01 | Insight
A neural epigenetic signature is prognostic in patients with glioblastoma - Nature Medicine
Nature Medicine recently shared a post on X: "A neural epigenetic signature detectable via plasma…
May 23, 2024, 12:46 | Blog
ESMO - This novel combination therapy holds great promise for BRCA-mutated metastatic Breast Cancers
ESMO shared a post on LinkedIn: "ESMOBreast24: phase 2 data on combining olaparib, durvalumab, and fulvestrant…
May 23, 2024, 12:42 | Opinion
Megan Hall: My colleague John Hennessy just shared the travel-time disparities in access to proton beam therapy for cancer treatment
Megan Hall, Chief Marketing and Creative Officer at Entrée Health, recently shared a post on…
All: 2435 Posts: 731 - 740
Special Coverage